Discriminating active from latent tuberculosis in patients presenting to community clinics.
about
Diagnostic 'omics' for active tuberculosisBiomarker discovery by sparse canonical correlation analysis of complex clinical phenotypes of tuberculosis and malariaThe human immune response to tuberculosis and its treatment: a view from the bloodGender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.What was old is new again: using the host response to diagnose infectious disease.Severe childhood malaria syndromes defined by plasma proteome profiles.Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment.Aerobiology and its role in the transmission of infectious diseases.Changes in tuberculin skin test positivity over 20 years in periurban shantytowns in Lima, Peru.Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosisThe dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis.Biomarkers of tuberculosis: a research roadmap.Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection.Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.Th1 cytokines, true functional signatures for protective immunity against TB?
P2860
Q26752536-C617EC83-6AC7-46D3-A829-C162E222409BQ28486273-7DC7511E-392B-4471-A281-01D8CA2B0402Q28544750-A0E4E721-F688-421A-917C-FF27874BEAF9Q30371254-13ED7825-0639-4C59-A087-9CC0C402651FQ30376327-985EC7F9-122F-4DCF-B6D0-2CE9E2C66BE1Q34506428-1C4C6DDB-4891-4C47-901C-09027B41C4ADQ35716029-92D7088F-50D3-4F5F-8980-DF972085AC8FQ36567324-5F31F996-629B-40B2-B13B-559FC920CA02Q37166136-BC2230CA-C90C-49E0-BC9C-4FD264F5BC54Q37247445-B4280928-163C-4515-BCB7-60441C14D05FQ38062582-611E8E7F-D2E1-4578-A077-99B55F0F0919Q38111807-A5B49206-08A3-4BA6-A2AB-55A73A89107FQ38849862-3E126D39-D1AA-42F5-B9AD-41D7DFC1DAAEQ40210450-9CAC0459-6D46-428B-9C4E-85F40C6DB04BQ49900955-29A5C13A-0BE9-4CD8-81D6-6A0C93BEB4CE
P2860
Discriminating active from latent tuberculosis in patients presenting to community clinics.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discriminating active from lat ...... esenting to community clinics.
@ast
Discriminating active from lat ...... esenting to community clinics.
@en
Discriminating active from lat ...... esenting to community clinics.
@nl
type
label
Discriminating active from lat ...... esenting to community clinics.
@ast
Discriminating active from lat ...... esenting to community clinics.
@en
Discriminating active from lat ...... esenting to community clinics.
@nl
prefLabel
Discriminating active from lat ...... esenting to community clinics.
@ast
Discriminating active from lat ...... esenting to community clinics.
@en
Discriminating active from lat ...... esenting to community clinics.
@nl
P2093
P2860
P50
P1433
P1476
Discriminating active from lat ...... esenting to community clinics.
@en
P2093
Barry K Ely
Daniel D Agranoff
Dimitrios Athanasakis
Francesca Battaglia
Gurjinder Sandhu
Jon S Friedland
Rosario Montoya
Teresa Valencia
P2860
P304
P356
10.1371/JOURNAL.PONE.0038080
P407
P577
2012-05-30T00:00:00Z